Vision protection therapy for prevention of neovascular age-related macular degeneration.

Sci Rep · 2023 · PMC10550910 · PMID 37794027

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Absent encounter matching the advantage to the VPT-treated eyes remained highly significant compared to the SCA group (avg 8.8 encounters, 12.5% conversion rate, HR 5.73) ( Supplemental Data ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.